Bladder Cancer

Latest News

Anktiva under review in UK for BCG-unresponsive NMIBC with CIS
Anktiva under review in UK for BCG-unresponsive NMIBC with CIS

February 17th 2025

Anktiva is also currently under review for the CIS indication in the EU.

Urinary bladder cancer | Image Credit: © Matthieu - stock.adobe.com
Disitamab vedotin plus toripalimab shows safety, efficacy in MIBC

February 16th 2025

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Additional NIAGARA data spotlight benefits of durvalumab plus chemo for MIBC

February 15th 2025

Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
Avelumab prolongs OS, PFS in advanced urothelial carcinoma irrespective of diabetes status

February 15th 2025

3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Real-world outcomes with nadofaragene point to safety, efficacy of NMIBC treatment

February 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.